Clinical trial site matching with improved diversity using fair policy learning
Authors:
Rakshith S Srinivasa,
Cheng Qian,
Brandon Theodorou,
Jeffrey Spaeder,
Cao Xiao,
Lucas Glass,
Jimeng Sun
Abstract:
The ongoing pandemic has highlighted the importance of reliable and efficient clinical trials in healthcare. Trial sites, where the trials are conducted, are chosen mainly based on feasibility in terms of medical expertise and access to a large group of patients. More recently, the issue of diversity and inclusion in clinical trials is gaining importance. Different patient groups may experience th…
▽ More
The ongoing pandemic has highlighted the importance of reliable and efficient clinical trials in healthcare. Trial sites, where the trials are conducted, are chosen mainly based on feasibility in terms of medical expertise and access to a large group of patients. More recently, the issue of diversity and inclusion in clinical trials is gaining importance. Different patient groups may experience the effects of a medical drug/ treatment differently and hence need to be included in the clinical trials. These groups could be based on ethnicity, co-morbidities, age, or economic factors. Thus, designing a method for trial site selection that accounts for both feasibility and diversity is a crucial and urgent goal. In this paper, we formulate this problem as a ranking problem with fairness constraints. Using principles of fairness in machine learning, we learn a model that maps a clinical trial description to a ranked list of potential trial sites. Unlike existing fairness frameworks, the group membership of each trial site is non-binary: each trial site may have access to patients from multiple groups. We propose fairness criteria based on demographic parity to address such a multi-group membership scenario. We test our method on 480 real-world clinical trials and show that our model results in a list of potential trial sites that provides access to a diverse set of patients while also ensuing a high number of enrolled patients.
△ Less
Submitted 13 April, 2022;
originally announced April 2022.
STAN: Spatio-Temporal Attention Network for Pandemic Prediction Using Real World Evidence
Authors:
Junyi Gao,
Rakshith Sharma,
Cheng Qian,
Lucas M. Glass,
Jeffrey Spaeder,
Justin Romberg,
Jimeng Sun,
Cao Xiao
Abstract:
Objective: The COVID-19 pandemic has created many challenges that need immediate attention. Various epidemiological and deep learning models have been developed to predict the COVID-19 outbreak, but all have limitations that affect the accuracy and robustness of the predictions. Our method aims at addressing these limitations and making earlier and more accurate pandemic outbreak predictions by (1…
▽ More
Objective: The COVID-19 pandemic has created many challenges that need immediate attention. Various epidemiological and deep learning models have been developed to predict the COVID-19 outbreak, but all have limitations that affect the accuracy and robustness of the predictions. Our method aims at addressing these limitations and making earlier and more accurate pandemic outbreak predictions by (1) using patients' EHR data from different counties and states that encode local disease status and medical resource utilization condition; (2) considering demographic similarity and geographical proximity between locations; and (3) integrating pandemic transmission dynamics into deep learning models. Materials and Methods: We proposed a spatio-temporal attention network (STAN) for pandemic prediction. It uses an attention-based graph convolutional network to capture geographical and temporal trends and predict the number of cases for a fixed number of days into the future. We also designed a physical law-based loss term for enhancing long-term prediction. STAN was tested using both massive real-world patient data and open source COVID-19 statistics provided by Johns Hopkins university across all U.S. counties. Results: STAN outperforms epidemiological modeling methods such as SIR and SEIR and deep learning models on both long-term and short-term predictions, achieving up to 87% lower mean squared error compared to the best baseline prediction model. Conclusions: By using information from real-world patient data and geographical data, STAN can better capture the disease status and medical resource utilization information and thus provides more accurate pandemic modeling. With pandemic transmission law based regularization, STAN also achieves good long-term prediction performance.
△ Less
Submitted 7 December, 2020; v1 submitted 23 July, 2020;
originally announced August 2020.